Clinical trials have shown that there is clearly a This work was supported by the Cystic Fibrosis requirement for newer approaches to improve deliv-Research Trust (SF) and a Wellcome Trust Senior ery and efficiency, increase duration of expression Clinical Fellowship (EWFWA). The authors are and permit repeated administration of GTAs. In members of the UK Cystic Fibrosis Gene Therapy addition there is an increasing need by the scientific Consortium (www.cfgenetherapy.org.uk). community that all these new GTAs and technologies are tested on relevant airway test systems (i.e., only highly differentiated epithelial cells in R eferences vitro and a spectrum of in vivo systems) before entering clinical trials. CF mice have been a great 


Section:. methodological issues a cknowledgements